HCC
ABBV icon

Hirtle Callaghan & Co’s AbbVie ABBV Stock Holding History

Hirtle Callaghan & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-69
Closed -$6K – 46
2019
Q1 		$6K Buy
+69
New +$5.64K ﹤0.01% 46
2018
Q2 		– Sell
-69
Closed -$7K – 107
2018
Q1 		$7K Hold
69
– – ﹤0.01% 99
2017
Q4 		$7K Buy
+69
New +$6.5K ﹤0.01% 113
2015
Q1 		– Sell
-22,044
Closed -$1.44M – 16
2014
Q4 		$1.44M Sell
22,044
-800
-4% -$50.4K 0.33% 47
2014
Q3 		$1.32M Sell
22,844
-340
-1% -$18.9K 0.22% 56
2014
Q2 		$1.31M Hold
23,184
– – 0.18% 79
2014
Q1 		$1.19M Sell
23,184
-320
-1% -$16.2K 0.2% 66
2013
Q4 		$1.24M Buy
23,504
+621
+3% +$30.5K 0.17% 68
2013
Q3 		$1.02M Buy
22,883
+19,601
+597% +$869K 0.17% 73
2013
Q2 		$136K Buy
+3,282
New +$144K 1.57% 19

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return